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ABSTRACT
Background. In terms of morbidity, prophylactic central
neck dissection (CND; level 6) in potentially malignant
thyroid disease is discussed controversially. The rates of
(transient and permanent) hypoparathyroidism and palsy of
the recurrent laryngeal nerve (RLN) after ‘‘first-step’’ (FS-)
CND are analyzed in this study.
Methods. Bilateral and unilateral FSCND, i.e., lymph
node dissection along the RLN before (total) thyroidec-
tomy, was performed bilaterally in 68 (group 1) and
unilaterally in 44 patients (group 2), respectively. The rates
of hypoparathyroidism and palsy of the RLN were docu-
mented prospectively and were compared to 237 patients of
group 3 (controls) who underwent (total) thyroidectomy
only.
Results. Fifteen of 68 patients (22 %) of group 1 devel-
oped transient and one patient had permanent
hypoparathyroidism. Transient unilateral palsy of the RLN
was observed in ten patients (15 %); none were permanent.
Transient hypoparathyroidism was monitored in 10 of 44
patients (23 %) of group 2 and permanent hypoparathy-
roidism in 1 (2 %). Six patients (14 %) developed
temporary palsy of the RLN; one remained permanent.
Palsy was seen in 3 patients on the contralateral side of
unilateral FSCND. Transient and permanent hypoparathy-
roidism was observed in 50 (21 %) and 2 (1 %) of 237
controls. Transient palsy of the RLN was documented in 22
(9 %) of 237 controls and permanent palsy of the RLN in 4
(2 %).
Conclusions. In this single-center series, the overall per-
manent morbidity was low (1 %). Therefore, FSCND may
be recommended (even prophylactically) for experienced
high-volume surgeons in patients with thyroid nodules
suspicious for malignancy.
Surgery for thyroid cancer includes lymph node dis-
section of the central neck compartment (CND; level 6).
This involves prelaryngeal, pretracheal, as well as lymph
nodes along and around both recurrent laryngeal nerves
(RLN) after removing the thyroid gland.1 Reviewing the
literature, many reports have summarized arguments for
and against this procedure in (suspected) follicular-derived
thyroid cancer.2 It is a wide consensus that therapeutic
initial CND is meaningful in cytologically proven malig-
nant diseases, as unsuspected metastatic lesions in the
central neck compartment are seen in up to 40 % of
cases.3–5 Prophylactic/therapeutic CND is recommended to
avoid the complications of reoperation and to establish
adequate staging to indicate further therapeutic options
(i.e., radioiodine ablation).6 In medullary thyroid carci-
noma (MTC), the prognostic value of (prophylactic) CND
has been documented.7
The purpose of this prospective observational study was
to evaluate the rate of permanent hypoparathyroidism and
palsy of the RLN in patients after (total) thyroidectomy
(TT) and ‘‘first-step’’ (FS-) unilateral and bilateral CND
compared to complications in patients with TT. The con-
troversies regarding whether to perform or not to perform
prophylactic CND are not discussed.
PATIENTS AND METHODS
A systematic analysis of a prospectively maintained
database comprising 112 patients who had received initial
TT and bilateral (group 1) or unilateral (group 2) FSCND
was performed and compared to a ‘‘control group’’ of 237
patients who had received TT only (group 3). The patients
were treated during a 3-year study period.
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Patients
Thyroid Metabolism All patients had normal thyroid-
stimulating hormone, Free T3, and Free T4 values.
Preoperative Ultrasonography Preoperative ultrasonog-
raphy of the thyroid gland and the central lymph node
compartment (level 6) was performed in all patients.
Bilateral thyroid nodules were documented in all patients.
There was no evidence of enlarged and thus suspicious
lymph nodes in the central neck (clinically/radiologically
N0 [c/r N0]).
Group 1: Bilateral FSCND was performed in 68 patients
(40 females, 28 males; mean age 42 years [range 9–81])
with biochemically verified or suspected MTC, as well as
patients with papillary thyroid carcinoma (PTC) diagnosed
by fine-needle aspiration biopsy and classified as Bethesda
VI (malignant).8
Group 2: Unilateral FSCND was performed in 44
patients (34 females, 10 males; mean age 52 years [range
15–87]) with thyroid nodules classified as ‘‘indeterminate
tumors’’ by fine-needle aspiration biopsy (Bethesda III–V).
In groups 1 and 2, a mean of 9 (range: 1–33) lymph nodes
were removed during uni- or bilateral FSCND.
Group 3: A total of 237 patients (191 females, 46 males;
mean age 54 years [range 16–87]) with benign bilateral
multinodular goiter and TT without FSCND provided as
controls. Concerning average gland weight and severity of
thyroiditis, there were no significant differences between
the three groups.
Surgical Technique
First-Step Central Neck Dissection (FSCND) By defi-
nition, lymphadenectomy of prelaryngeal, pretracheal, and
unilateral or bilateral along the RLN (CND; clearance of
level 6) was performed after extended mobilization of the
upper and lower poles of the thyroid gland.9 Pulling the
thyroid lobe upward and medially allowed optimal
palpation, visualization, and dissection of the RLN.
Before removing the thyroid lobe, the lymphatic tissue
was dissected along the RLN. This surgical maneuver was
performed prophylactically before removing one or both
thyroid lobes.
The surgical procedures were performed in a university
hospital (the Section of Endocrine Surgery, a tertiary
referral center) by two experienced endocrine surgeons
(C.S. and B.N.; case load/year: [100 procedures). All
patients gave informed consent to all diagnostic and ther-
apeutic procedures. The prospective data collection and the
retrospective analysis were approved by the Ethics Com-
mittee of the Medical University of Vienna (approval
number 1943/2012).
Parathyroid Autotransplantation
Whenever feasible, all four parathyroid glands were
visualized and carefully dissected from the thyroid capsule.
Once the blood supply was preserved, the parathyroids
were kept in situ. If the blood supply of a parathyroid gland
could not be maintained or hypovascularization was sus-
pected, the gland was removed and organ diagnosis was
confirmed by frozen section. The gland was subsequently
stored at 4 C in 0.9 % NaCl until the end of the surgical
procedure and then immediately autotransplanted into the
sternocleidomastoid muscle according to a standard pro-
cedure before closing the wound.10
In all patients with parathyroid autotransplantation, at
least two additional parathyroids were visualized during
surgery and left in situ with an optimal vascular supply.
Synchronous parathyroid autotransplantation was per-
formed in 30 of 68 patients (44 %) of group 1, in 9 of 44
patients (20 %) of group 2, and in 53 of 237 patients
(22 %) of group 3. The rate of parathyroid autotransplan-
tation was significantly higher in the group with bilateral
FSCND (p B 0.05).
Frozen Section
Frozen section was performed in all specimens. Only
patients with ‘‘initial FSCND’’ were included in the anal-
ysis. If malignancy was proven intraoperatively, CND was
extended to the contralateral side as a ‘‘second step
procedure.’’ These patients were excluded from this com-
parative analysis.
Parathyroid Metabolism
Measurement of albumin-adjusted total serum calcium
(sCa), intact parathyroid hormone (iPTH), and creatinine
was performed preoperatively, in the morning of the first
postoperative day, and during follow-up 1 and 6 months
postoperatively.11 SCa (normal range: 2.0–2.6 mmol/l) was
measured on a conventional standard autoanalyzer and
iPTH (normal range: 15–65 pg/ml) using a commercially
available iPTH assay (Elecsys 1010; Roche Diagnostics;
Mannheim, Germany).
Follow-up
Patients with a disturbed parathyroid metabolism on the
first postoperative day and/or a limited function of the
recurrent laryngeal nerve between days 1 and 5 postoper-
atively were followed at least 1 year (see definitions
below).
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Definition of Postoperative Hypoparathyroidism
Postoperative hypoparathyroidism was defined as
parathyroid hormone levels \15 pg/ml on the first post-
operative day with coincident inadequately low calcium
and the need for calcium and vitamin D supplementation
regardless of the presence of symptoms.11 Postoperative
hypoparathyroidism was defined as ‘‘transient’’ if iPTH and
sCa normalized within 6 months. When serum levels of
iPTH and Ca were still below the reference range and if
patients were taking calcium and vitamin D medication
after 6 months, hypoparathyroidism was defined as
‘‘permanent.’’
Laryngological Evaluation
FSCND was accompanied by extended dissection of the
(inferior) RLN without intraoperative neuromonitoring.12
All patients presented with a normal preoperative level of
vocal cord mobility. Between days 1 and 5, postoperative
laryngoscopy was performed routinely.
Definition of a Postoperative Disturbance of the RLN
Function
Irritation of the RLN was classified as transient in the
presence of temporary hoarseness based on vocal cord
immobility at laryngoscopy. When vocal cord immobility
was observed, further follow-up to classify transient/per-
manent RLN palsy was applied. Permanent hoarseness
accompanied by paralysis of the vocal cord(s) at laryn-
goscopy for longer than 6 months was defined as a
permanent complication.
Statistical Analysis
Data were analyzed by descriptive statistics and the Chi
square test using Microsoft Excel (Microsoft Corporation,
Roselle, IL). The level of significance was set at p\ 0.05.
RESULTS
Morbidity
Hypoparathyroidism and paralysis of the RLN in the
three patient groups are summarized in Table 1.
Postoperative Hypoparathyroidism and Parathyroid
Autotransplantation
Synchronous parathyroid autotransplantation was per-
formed in 30 of 68 patients (44 %) of group 1, in 9 of 44
patients (20 %) of group 2, and in 53 of 237 patients
(22 %) of group 3. The rate of parathyroid autotransplan-
tation was significantly higher in the group with bilateral
FSCND (p\ 0.05).
Fifteen patients (22 %) of group 1 developed transient
and one (1 %) permanent hypoparathyroidism. In group 2,
ten patients (23 %) developed transient and one (2 %)
permanent hypoparathyroidism. In group 3, temporary and
permanent hypoparathyroidism were seen in 50 (21 %) and
2 (1 %) patients, respectively. Comparing groups 1 and 2
with group 3, no significant differences were identified.
Palsy of the RLN
Unilateral transient palsy of the RLN was observed in
ten patients (15 %) of group 1. Neither bilateral nor per-
manent paresis was observed in this patients group.
In group 2, six patients (14 %) developed transient palsy
of the RLN, one (2 %) remained permanent. The nerve
palsy was documented in three of the six patients on the
side of FSCND (including the permanent palsy). In the
other three patients, the transient nerve palsy was described
on the contralateral side of the FSCND.
In group 3, 22 of 237 patients (9 %) developed transient
and 4 (2 %) permanent unilateral palsy of the RLN.
Details concerning transient and permanent palsy of the
RLN subdividing patients with nerves at ‘‘high risk’’
(FSCND) and patients with nerves at ‘‘normal risk’’ (no
TABLE 1 Overview of complication rates depicting insignificant differences between the groups
n Hypoparathyroidism n (%) Recurrent laryngeal nerve palsy n (%)
Transient Permanent Transient Permanent
Group 1 (thyroidectomy ? bilateral FSCND) 68 15 (22) 1 (1) 10 (15) 0
Group 2 (thyroidectomy ? unilateral FSCND) 44 10 (23) 1 (2) 6 (14) 1 (2)
Group 3 (thyroidectomy) 237 50 (21) 2 (1) 22 (9) 4 (2)
Total 349 75 (21) 4 (1) 38 (11) 5 (1)
FSCND first-step central neck dissection
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FSCND) are depicted in Table 2. No statistical significance
was documented comparing groups 1 and 2 with group 3.
Final Histological Results
As summarized in Table 3 (not including patients with
TT without CND and therefore unknown lymph nodes
status), the final histological reports revealed various types
of malignancy in 55 of 68 patients (81 %) of group 1 and in
25 of 44 patients (57 %) of group 2, respectively. Overall,
lymph-node metastases (mean 5; range 1–16 nodes) were
documented in 39 of 80 patients (49 %), in 35 (51 %) of
group 1, and in 4 (9 %) of group 2, respectively.
DISCUSSION
Many surgeons avoid (prophylactic) CND as an initial
procedure in suspected or verified malignant thyroid micro-
disease (tumor diameter B10 mm; UICC 2009 pT1a) due
to an overall high complication rate, although a high rate of
clinically and sonographically unsuspected lymph node
metastasis may be revealed.13–15 However, the majority of
authors have recommended (prophylactic/therapeutic)
CND in malignant thyroid macro-disease (tumor diameter
[11 mm; UICC 2009 CpT1b).16
In this single-center study, uni- or bilateral CND as a
first-step procedure was performed prophylactically in
nodules with a ‘‘high risk of malignancy’’ and c/r N0.9 The
morbidity associated with extended prophylactic CND was
compared to the lesser extent of applied lymph node sur-
gery. The overall rate of permanent morbidity was 1 %,
with no significant difference between patients with or
without CND.
Following TT, transient and permanent hypoparathy-
roidism were documented in 21 and 1 % of cases,
respectively. There was no statistically significant differ-
ence between procedures without (21 and 1 %) and with
unilateral (23 and 2 %) and/or bilateral FSCND (22 and
1 %). A standardized protocol was applied in the current
study to diagnose and define temporary and permanent
postoperative hypoparathyroidism based on PTH levels
after TT.11
Depending on the definition based on calcium alone or
on calcium in combination with PTH, there have been
variations in reporting temporary and permanent
hypoparathyroidism in various studies, thus making it dif-
ficult to compare the complication rates. In the literature,
however, transient hypoparathyroidism has been reported
to be between 9.7 and 56.5 % after TT with bilateral CND
(Table 4). The same authors have described this compli-
cation in 4–33.6 % of cases, necessitating temporary
calcium and vitamin D substitution after simple TT. A
permanent disturbance of the parathyroid metabolism has
been reported in up to 19.4 % after CND compared to
between 0.6 and 8.1 % after simple TT.
In a recently published meta-analysis of prophylactic
CND, temporary hypocalcemia was the major surgical
morbidity in patients with prophylactic CND, yet when
excluded, overall morbidity appeared similar comparing
the patients groups who had undergone TT with CND.17
Every effort is to be made to preserve viable parathyroid
tissue, in particular the superior glands, as the inferior
TABLE 2 Subdivision of patients with nerves at ‘‘high risk’’ (FSCND) and patients with nerves at ‘‘normal risk’’ (no FSCND)
Group Patients Nerves at risk Nerves at high/normal risk Nerves at high risk (=with FSCND) Nerves at normal risk (=without FSCND)
n n Transient Permanent Transient Permanent Transient Permanent
n % n % n % n % n % n %
I 68 136 10/136 7.4 0 0 10/136 7.4 0 0
II 44 88 6/88 6.8 1/88 1.1 3/44 6.8 1/44 2.3 3/44 6.8 0 0
III 237 474 22/474 4.8 4/474 0.8 22/474 4.8 4/474 0.8
R 349 698 38/698 5.4 5/698 0.7 13/180 7.2 1/180 0.6 27/518 5.2 4/518 0.7
FSCND first-step central neck dissection
TABLE 3 Final histologic evaluations (not including patients with TT without FSCND)
Surgical procedure Final histological results
N Carcinoma with lymph node metastasis Carcinoma without lymph node involvement Benign
Thyroidectomy ? bilateral FSCND 68 35 (51 %) 20 (29 %) 13 (19 %)
Thyroidectomy ? unilateral FSCND 44 4 (9 %) 21 (48 %) 19 (43 %)
FSCND first-step central neck dissection
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glands are more likely to be damaged or excised in the
course of CND. Prophylactic parathyroid autotransplanta-
tion may reduce permanent hypoparathyroidism.18,19
In the current analysis, a significant difference was
identified between the groups regarding the rates of
parathyroid autotransplantation. As expected, the number
of autotransplanted patients was significantly higher in the
presence of bilateral FSCND, indicating that parathyroid
autotransplantation of one gland may neither decrease nor
increase the rate of transient or permanent hypoparathy-
roidism if at least two additional parathyroids are left
in situ and well vascularized.20
Transient and permanent unilateral paralysis of the
RLN nerve were revealed in 8.9 and 0.6 % of nerves at
risk, respectively. There was no statistical significance
comparing procedures with and without FSCND.
Data in the literature have reported temporary or per-
manent paralysis of the RLN after simple TT of up to 8 %
and, in more extended procedures, of between 0.4 and
9.8 %. The addition of CND to TT has been reported to
increase neither the risk of temporary nor of permanent
vocal cord paralysis in prophylactic or therapeutic
procedures.17,21–37
Because of the inhomogeneous patients groups descri-
bed in the literature and the lack of routine postoperative
laryngoscopy in many studies, no statistical comparison
with the current analysis was possible. However, primary
(uni- or bilateral) FSCND comprises—in accordance with
literature—at least the same or even a lower rate of per-
manent paralysis.
In MTC, CND is recommended in various international
guidelines but is still a subject of controversy in PTC man-
agement regarding routine or therapeutic indications and its
impact on local recurrence and survival. The overall low rate
of permanent morbidity in this study warrants the recom-
mendation of (even prophylactic) FSCND in all patients with
suspicious thyroid nodules, thus improving cancer staging
and avoiding more complicated second step reoperations
comprising a higher level of (permanent) complications.
However, these data represent the unique experience of a
specialized high-volume centre and may not be transferable
to other institutions with lower caseloads.
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